nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketorolac—PTGS2—stomach cancer	0.604	1	CbGaD
Ketorolac—Tolmetin—CXCL8—stomach cancer	0.00172	0.272	CrCbGaD
Ketorolac—Ketoprofen—CXCL8—stomach cancer	0.00084	0.133	CrCbGaD
Ketorolac—PTGS1—blood vessel—stomach cancer	0.000835	0.113	CbGeAlD
Ketorolac—PTGS2—blood vessel—stomach cancer	0.000798	0.108	CbGeAlD
Ketorolac—PTGS2—gall bladder—stomach cancer	0.000751	0.101	CbGeAlD
Ketorolac—Tiaprofenic acid—PTGS2—stomach cancer	0.000636	0.1	CrCbGaD
Ketorolac—Nepafenac—PTGS2—stomach cancer	0.000605	0.0955	CrCbGaD
Ketorolac—Fenbufen—PTGS2—stomach cancer	0.000578	0.0913	CrCbGaD
Ketorolac—Tolmetin—PTGS2—stomach cancer	0.000502	0.0794	CrCbGaD
Ketorolac—Salsalate—PTGS2—stomach cancer	0.000502	0.0794	CrCbGaD
Ketorolac—Suprofen—PTGS2—stomach cancer	0.000482	0.0761	CrCbGaD
Ketorolac—PTGS1—hematopoietic system—stomach cancer	0.000445	0.0601	CbGeAlD
Ketorolac—PTGS2—hematopoietic system—stomach cancer	0.000425	0.0574	CbGeAlD
Ketorolac—PTGS1—epithelium—stomach cancer	0.000406	0.0549	CbGeAlD
Ketorolac—PTGS1—smooth muscle tissue—stomach cancer	0.000392	0.0529	CbGeAlD
Ketorolac—PTGS2—epithelium—stomach cancer	0.000388	0.0525	CbGeAlD
Ketorolac—PTGS2—smooth muscle tissue—stomach cancer	0.000374	0.0506	CbGeAlD
Ketorolac—PTGS2—pancreas—stomach cancer	0.000346	0.0467	CbGeAlD
Ketorolac—PTGS1—digestive system—stomach cancer	0.000309	0.0418	CbGeAlD
Ketorolac—PTGS2—lymphoid tissue—stomach cancer	0.000299	0.0404	CbGeAlD
Ketorolac—PTGS2—digestive system—stomach cancer	0.000296	0.0399	CbGeAlD
Ketorolac—PTGS2—bone marrow—stomach cancer	0.000272	0.0368	CbGeAlD
Ketorolac—PTGS1—endocrine gland—stomach cancer	0.000255	0.0345	CbGeAlD
Ketorolac—Ketoprofen—PTGS2—stomach cancer	0.000245	0.0387	CrCbGaD
Ketorolac—PTGS2—endocrine gland—stomach cancer	0.000244	0.033	CbGeAlD
Ketorolac—PTGS2—liver—stomach cancer	0.00022	0.0297	CbGeAlD
Ketorolac—Ketoprofen—ALB—stomach cancer	0.000218	0.0345	CrCbGaD
Ketorolac—PTGS2—Selenium Micronutrient Network—SOD2—stomach cancer	0.000177	0.00373	CbGpPWpGaD
Ketorolac—PTGS1—lymph node—stomach cancer	0.000177	0.0239	CbGeAlD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—PPAP2A—stomach cancer	0.000176	0.00371	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—RARB—stomach cancer	0.000175	0.0037	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—APEX1—stomach cancer	0.00017	0.00358	CbGpPWpGaD
Ketorolac—PTGS2—lymph node—stomach cancer	0.000169	0.0228	CbGeAlD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—CDKN1B—stomach cancer	0.000158	0.00333	CbGpPWpGaD
Ketorolac—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—stomach cancer	0.000157	0.00332	CbGpPWpGaD
Ketorolac—PTGS2—Selenium Micronutrient Network—MTHFR—stomach cancer	0.000156	0.00329	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—IGFBP3—stomach cancer	0.000152	0.00322	CbGpPWpGaD
Ketorolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—stomach cancer	0.000151	0.00319	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—PLIN2—stomach cancer	0.000147	0.00311	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—BDNF—stomach cancer	0.000146	0.00308	CbGpPWpGaD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—CDKN1A—stomach cancer	0.000146	0.00308	CbGpPWpGaD
Ketorolac—PTGS2—Selenium Micronutrient Network—APOA1—stomach cancer	0.000143	0.00302	CbGpPWpGaD
Ketorolac—PTGS1—Selenium Micronutrient Network—SERPINE1—stomach cancer	0.000143	0.00302	CbGpPWpGaD
Ketorolac—PTGS1—Selenium Micronutrient Network—ALB—stomach cancer	0.000143	0.00302	CbGpPWpGaD
Ketorolac—PTGS1—Biological oxidations—GSTP1—stomach cancer	0.000141	0.00298	CbGpPWpGaD
Ketorolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUN—stomach cancer	0.000141	0.00297	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—PPAP2A—stomach cancer	0.00014	0.00294	CbGpPWpGaD
Ketorolac—Insomnia—Capecitabine—stomach cancer	0.000138	0.000413	CcSEcCtD
Ketorolac—Rash—Fluorouracil—stomach cancer	0.000138	0.000412	CcSEcCtD
Ketorolac—Dermatitis—Fluorouracil—stomach cancer	0.000138	0.000411	CcSEcCtD
Ketorolac—Paraesthesia—Capecitabine—stomach cancer	0.000137	0.00041	CcSEcCtD
Ketorolac—Decreased appetite—Docetaxel—stomach cancer	0.000137	0.00041	CcSEcCtD
Ketorolac—Headache—Fluorouracil—stomach cancer	0.000137	0.000409	CcSEcCtD
Ketorolac—Urinary tract disorder—Doxorubicin—stomach cancer	0.000137	0.000409	CcSEcCtD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—ANXA1—stomach cancer	0.000137	0.00288	CbGpPWpGaD
Ketorolac—Dysgeusia—Methotrexate—stomach cancer	0.000136	0.000408	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000136	0.000407	CcSEcCtD
Ketorolac—Connective tissue disorder—Doxorubicin—stomach cancer	0.000136	0.000407	CcSEcCtD
Ketorolac—Dyspnoea—Capecitabine—stomach cancer	0.000136	0.000407	CcSEcCtD
Ketorolac—Fatigue—Docetaxel—stomach cancer	0.000136	0.000406	CcSEcCtD
Ketorolac—Angiopathy—Epirubicin—stomach cancer	0.000136	0.000406	CcSEcCtD
Ketorolac—Urethral disorder—Doxorubicin—stomach cancer	0.000136	0.000406	CcSEcCtD
Ketorolac—Nausea—Irinotecan—stomach cancer	0.000136	0.000405	CcSEcCtD
Ketorolac—Immune system disorder—Epirubicin—stomach cancer	0.000135	0.000404	CcSEcCtD
Ketorolac—Mediastinal disorder—Epirubicin—stomach cancer	0.000135	0.000403	CcSEcCtD
Ketorolac—Pain—Docetaxel—stomach cancer	0.000135	0.000403	CcSEcCtD
Ketorolac—Constipation—Docetaxel—stomach cancer	0.000135	0.000403	CcSEcCtD
Ketorolac—Back pain—Methotrexate—stomach cancer	0.000135	0.000403	CcSEcCtD
Ketorolac—Dyspepsia—Capecitabine—stomach cancer	0.000134	0.000402	CcSEcCtD
Ketorolac—Chills—Epirubicin—stomach cancer	0.000134	0.000401	CcSEcCtD
Ketorolac—Arrhythmia—Epirubicin—stomach cancer	0.000134	0.0004	CcSEcCtD
Ketorolac—Visual impairment—Doxorubicin—stomach cancer	0.000134	0.000399	CcSEcCtD
Ketorolac—Decreased appetite—Capecitabine—stomach cancer	0.000133	0.000397	CcSEcCtD
Ketorolac—Alopecia—Epirubicin—stomach cancer	0.000132	0.000395	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000132	0.000394	CcSEcCtD
Ketorolac—Fatigue—Capecitabine—stomach cancer	0.000132	0.000393	CcSEcCtD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—stomach cancer	0.000131	0.00277	CbGpPWpGaD
Ketorolac—Vision blurred—Methotrexate—stomach cancer	0.000131	0.000392	CcSEcCtD
Ketorolac—Mental disorder—Epirubicin—stomach cancer	0.000131	0.000392	CcSEcCtD
Ketorolac—Erythema multiforme—Doxorubicin—stomach cancer	0.000131	0.000391	CcSEcCtD
Ketorolac—Pain—Capecitabine—stomach cancer	0.000131	0.00039	CcSEcCtD
Ketorolac—Constipation—Capecitabine—stomach cancer	0.000131	0.00039	CcSEcCtD
Ketorolac—Malnutrition—Epirubicin—stomach cancer	0.00013	0.000389	CcSEcCtD
Ketorolac—Erythema—Epirubicin—stomach cancer	0.00013	0.000389	CcSEcCtD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—GADD45A—stomach cancer	0.00013	0.00275	CbGpPWpGaD
Ketorolac—Feeling abnormal—Docetaxel—stomach cancer	0.00013	0.000388	CcSEcCtD
Ketorolac—Nausea—Fluorouracil—stomach cancer	0.00013	0.000388	CcSEcCtD
Ketorolac—PTGS1—Biological oxidations—GSTM1—stomach cancer	0.00013	0.00274	CbGpPWpGaD
Ketorolac—Eye disorder—Doxorubicin—stomach cancer	0.00013	0.000387	CcSEcCtD
Ketorolac—Ill-defined disorder—Methotrexate—stomach cancer	0.000129	0.000386	CcSEcCtD
Ketorolac—Tinnitus—Doxorubicin—stomach cancer	0.000129	0.000386	CcSEcCtD
Ketorolac—Gastrointestinal pain—Docetaxel—stomach cancer	0.000129	0.000385	CcSEcCtD
Ketorolac—Anaemia—Methotrexate—stomach cancer	0.000129	0.000385	CcSEcCtD
Ketorolac—Flushing—Doxorubicin—stomach cancer	0.000129	0.000384	CcSEcCtD
Ketorolac—Cardiac disorder—Doxorubicin—stomach cancer	0.000129	0.000384	CcSEcCtD
Ketorolac—Flatulence—Epirubicin—stomach cancer	0.000129	0.000384	CcSEcCtD
Ketorolac—Tension—Epirubicin—stomach cancer	0.000128	0.000382	CcSEcCtD
Ketorolac—Dysgeusia—Epirubicin—stomach cancer	0.000128	0.000381	CcSEcCtD
Ketorolac—Nervousness—Epirubicin—stomach cancer	0.000127	0.000378	CcSEcCtD
Ketorolac—Back pain—Epirubicin—stomach cancer	0.000126	0.000377	CcSEcCtD
Ketorolac—Feeling abnormal—Capecitabine—stomach cancer	0.000126	0.000376	CcSEcCtD
Ketorolac—Angiopathy—Doxorubicin—stomach cancer	0.000126	0.000376	CcSEcCtD
Ketorolac—Malaise—Methotrexate—stomach cancer	0.000126	0.000375	CcSEcCtD
Ketorolac—Immune system disorder—Doxorubicin—stomach cancer	0.000125	0.000374	CcSEcCtD
Ketorolac—Vertigo—Methotrexate—stomach cancer	0.000125	0.000374	CcSEcCtD
Ketorolac—PTGS1—Selenium Micronutrient Network—PTGS2—stomach cancer	0.000125	0.00264	CbGpPWpGaD
Ketorolac—Gastrointestinal pain—Capecitabine—stomach cancer	0.000125	0.000373	CcSEcCtD
Ketorolac—Mediastinal disorder—Doxorubicin—stomach cancer	0.000125	0.000373	CcSEcCtD
Ketorolac—Body temperature increased—Docetaxel—stomach cancer	0.000125	0.000373	CcSEcCtD
Ketorolac—Abdominal pain—Docetaxel—stomach cancer	0.000125	0.000373	CcSEcCtD
Ketorolac—Leukopenia—Methotrexate—stomach cancer	0.000125	0.000373	CcSEcCtD
Ketorolac—Chills—Doxorubicin—stomach cancer	0.000124	0.000371	CcSEcCtD
Ketorolac—Arrhythmia—Doxorubicin—stomach cancer	0.000124	0.00037	CcSEcCtD
Ketorolac—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—stomach cancer	0.000124	0.00261	CbGpPWpGaD
Ketorolac—Vision blurred—Epirubicin—stomach cancer	0.000123	0.000367	CcSEcCtD
Ketorolac—Alopecia—Doxorubicin—stomach cancer	0.000122	0.000366	CcSEcCtD
Ketorolac—Cough—Methotrexate—stomach cancer	0.000122	0.000363	CcSEcCtD
Ketorolac—PTGS1—Metabolism—ACAD8—stomach cancer	0.000121	0.00256	CbGpPWpGaD
Ketorolac—Mental disorder—Doxorubicin—stomach cancer	0.000121	0.000363	CcSEcCtD
Ketorolac—Urticaria—Capecitabine—stomach cancer	0.000121	0.000362	CcSEcCtD
Ketorolac—Ill-defined disorder—Epirubicin—stomach cancer	0.000121	0.000361	CcSEcCtD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—MYC—stomach cancer	0.000121	0.00255	CbGpPWpGaD
Ketorolac—Body temperature increased—Capecitabine—stomach cancer	0.000121	0.000361	CcSEcCtD
Ketorolac—Abdominal pain—Capecitabine—stomach cancer	0.000121	0.000361	CcSEcCtD
Ketorolac—Convulsion—Methotrexate—stomach cancer	0.000121	0.000361	CcSEcCtD
Ketorolac—Malnutrition—Doxorubicin—stomach cancer	0.000121	0.00036	CcSEcCtD
Ketorolac—Erythema—Doxorubicin—stomach cancer	0.000121	0.00036	CcSEcCtD
Ketorolac—Anaemia—Epirubicin—stomach cancer	0.000121	0.00036	CcSEcCtD
Ketorolac—Agitation—Epirubicin—stomach cancer	0.00012	0.000358	CcSEcCtD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—CHEK2—stomach cancer	0.000119	0.00251	CbGpPWpGaD
Ketorolac—Flatulence—Doxorubicin—stomach cancer	0.000119	0.000355	CcSEcCtD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—ECHS1—stomach cancer	0.000119	0.0025	CbGpPWpGaD
Ketorolac—Myalgia—Methotrexate—stomach cancer	0.000119	0.000354	CcSEcCtD
Ketorolac—Chest pain—Methotrexate—stomach cancer	0.000119	0.000354	CcSEcCtD
Ketorolac—Arthralgia—Methotrexate—stomach cancer	0.000119	0.000354	CcSEcCtD
Ketorolac—Tension—Doxorubicin—stomach cancer	0.000118	0.000354	CcSEcCtD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—MAPK1—stomach cancer	0.000118	0.0025	CbGpPWpGaD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—EGFR—stomach cancer	0.000118	0.0025	CbGpPWpGaD
Ketorolac—Dysgeusia—Doxorubicin—stomach cancer	0.000118	0.000353	CcSEcCtD
Ketorolac—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000118	0.000352	CcSEcCtD
Ketorolac—Malaise—Epirubicin—stomach cancer	0.000118	0.000351	CcSEcCtD
Ketorolac—Discomfort—Methotrexate—stomach cancer	0.000117	0.00035	CcSEcCtD
Ketorolac—Nervousness—Doxorubicin—stomach cancer	0.000117	0.00035	CcSEcCtD
Ketorolac—Vertigo—Epirubicin—stomach cancer	0.000117	0.00035	CcSEcCtD
Ketorolac—Syncope—Epirubicin—stomach cancer	0.000117	0.000349	CcSEcCtD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—PLIN2—stomach cancer	0.000117	0.00247	CbGpPWpGaD
Ketorolac—Leukopenia—Epirubicin—stomach cancer	0.000117	0.000349	CcSEcCtD
Ketorolac—Back pain—Doxorubicin—stomach cancer	0.000117	0.000349	CcSEcCtD
Ketorolac—PTGS1—Selenium Micronutrient Network—IL1B—stomach cancer	0.000116	0.00246	CbGpPWpGaD
Ketorolac—Hypersensitivity—Docetaxel—stomach cancer	0.000116	0.000347	CcSEcCtD
Ketorolac—Palpitations—Epirubicin—stomach cancer	0.000115	0.000344	CcSEcCtD
Ketorolac—Confusional state—Methotrexate—stomach cancer	0.000115	0.000342	CcSEcCtD
Ketorolac—Loss of consciousness—Epirubicin—stomach cancer	0.000115	0.000342	CcSEcCtD
Ketorolac—Cough—Epirubicin—stomach cancer	0.000114	0.00034	CcSEcCtD
Ketorolac—Anaphylactic shock—Methotrexate—stomach cancer	0.000114	0.00034	CcSEcCtD
Ketorolac—PTGS2—Selenium Micronutrient Network—SERPINE1—stomach cancer	0.000114	0.0024	CbGpPWpGaD
Ketorolac—Vision blurred—Doxorubicin—stomach cancer	0.000114	0.00034	CcSEcCtD
Ketorolac—PTGS2—Selenium Micronutrient Network—ALB—stomach cancer	0.000114	0.0024	CbGpPWpGaD
Ketorolac—Asthenia—Docetaxel—stomach cancer	0.000113	0.000338	CcSEcCtD
Ketorolac—Convulsion—Epirubicin—stomach cancer	0.000113	0.000337	CcSEcCtD
Ketorolac—Infection—Methotrexate—stomach cancer	0.000113	0.000337	CcSEcCtD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—TNF—stomach cancer	0.000113	0.00238	CbGpPWpGaD
Ketorolac—Hypertension—Epirubicin—stomach cancer	0.000113	0.000336	CcSEcCtD
Ketorolac—Hypersensitivity—Capecitabine—stomach cancer	0.000113	0.000336	CcSEcCtD
Ketorolac—Ill-defined disorder—Doxorubicin—stomach cancer	0.000112	0.000334	CcSEcCtD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—KRAS—stomach cancer	0.000112	0.00236	CbGpPWpGaD
Ketorolac—Pruritus—Docetaxel—stomach cancer	0.000112	0.000333	CcSEcCtD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—FADS1—stomach cancer	0.000112	0.00235	CbGpPWpGaD
Ketorolac—Nervous system disorder—Methotrexate—stomach cancer	0.000112	0.000333	CcSEcCtD
Ketorolac—Anaemia—Doxorubicin—stomach cancer	0.000112	0.000333	CcSEcCtD
Ketorolac—Thrombocytopenia—Methotrexate—stomach cancer	0.000111	0.000333	CcSEcCtD
Ketorolac—Chest pain—Epirubicin—stomach cancer	0.000111	0.000332	CcSEcCtD
Ketorolac—Arthralgia—Epirubicin—stomach cancer	0.000111	0.000332	CcSEcCtD
Ketorolac—Myalgia—Epirubicin—stomach cancer	0.000111	0.000332	CcSEcCtD
Ketorolac—Agitation—Doxorubicin—stomach cancer	0.000111	0.000331	CcSEcCtD
Ketorolac—Anxiety—Epirubicin—stomach cancer	0.000111	0.00033	CcSEcCtD
Ketorolac—Skin disorder—Methotrexate—stomach cancer	0.00011	0.00033	CcSEcCtD
Ketorolac—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.00011	0.000329	CcSEcCtD
Ketorolac—PTGS2—C-MYB transcription factor network—CDKN2A—stomach cancer	0.00011	0.00233	CbGpPWpGaD
Ketorolac—Hyperhidrosis—Methotrexate—stomach cancer	0.00011	0.000328	CcSEcCtD
Ketorolac—PTGS2—Spinal Cord Injury—CDK4—stomach cancer	0.00011	0.00232	CbGpPWpGaD
Ketorolac—Discomfort—Epirubicin—stomach cancer	0.00011	0.000328	CcSEcCtD
Ketorolac—Asthenia—Capecitabine—stomach cancer	0.00011	0.000327	CcSEcCtD
Ketorolac—Malaise—Doxorubicin—stomach cancer	0.000109	0.000325	CcSEcCtD
Ketorolac—Dry mouth—Epirubicin—stomach cancer	0.000109	0.000324	CcSEcCtD
Ketorolac—Vertigo—Doxorubicin—stomach cancer	0.000108	0.000324	CcSEcCtD
Ketorolac—Anorexia—Methotrexate—stomach cancer	0.000108	0.000324	CcSEcCtD
Ketorolac—PTGS1—Metabolism—GMPR2—stomach cancer	0.000108	0.00228	CbGpPWpGaD
Ketorolac—Syncope—Doxorubicin—stomach cancer	0.000108	0.000323	CcSEcCtD
Ketorolac—Pruritus—Capecitabine—stomach cancer	0.000108	0.000323	CcSEcCtD
Ketorolac—Leukopenia—Doxorubicin—stomach cancer	0.000108	0.000323	CcSEcCtD
Ketorolac—Diarrhoea—Docetaxel—stomach cancer	0.000108	0.000322	CcSEcCtD
Ketorolac—Confusional state—Epirubicin—stomach cancer	0.000107	0.000321	CcSEcCtD
Ketorolac—Palpitations—Doxorubicin—stomach cancer	0.000107	0.000318	CcSEcCtD
Ketorolac—Anaphylactic shock—Epirubicin—stomach cancer	0.000106	0.000318	CcSEcCtD
Ketorolac—Oedema—Epirubicin—stomach cancer	0.000106	0.000318	CcSEcCtD
Ketorolac—Hypotension—Methotrexate—stomach cancer	0.000106	0.000317	CcSEcCtD
Ketorolac—Loss of consciousness—Doxorubicin—stomach cancer	0.000106	0.000317	CcSEcCtD
Ketorolac—Infection—Epirubicin—stomach cancer	0.000106	0.000316	CcSEcCtD
Ketorolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—stomach cancer	0.000105	0.00222	CbGpPWpGaD
Ketorolac—Cough—Doxorubicin—stomach cancer	0.000105	0.000314	CcSEcCtD
Ketorolac—Shock—Epirubicin—stomach cancer	0.000105	0.000313	CcSEcCtD
Ketorolac—Convulsion—Doxorubicin—stomach cancer	0.000105	0.000312	CcSEcCtD
Ketorolac—Diarrhoea—Capecitabine—stomach cancer	0.000105	0.000312	CcSEcCtD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—SREBF2—stomach cancer	0.000105	0.00221	CbGpPWpGaD
Ketorolac—Nervous system disorder—Epirubicin—stomach cancer	0.000104	0.000312	CcSEcCtD
Ketorolac—Dizziness—Docetaxel—stomach cancer	0.000104	0.000312	CcSEcCtD
Ketorolac—Thrombocytopenia—Epirubicin—stomach cancer	0.000104	0.000311	CcSEcCtD
Ketorolac—Hypertension—Doxorubicin—stomach cancer	0.000104	0.000311	CcSEcCtD
Ketorolac—Tachycardia—Epirubicin—stomach cancer	0.000104	0.00031	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000104	0.000309	CcSEcCtD
Ketorolac—Skin disorder—Epirubicin—stomach cancer	0.000103	0.000309	CcSEcCtD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—RORA—stomach cancer	0.000103	0.00218	CbGpPWpGaD
Ketorolac—Hyperhidrosis—Epirubicin—stomach cancer	0.000103	0.000307	CcSEcCtD
Ketorolac—Insomnia—Methotrexate—stomach cancer	0.000103	0.000307	CcSEcCtD
Ketorolac—Arthralgia—Doxorubicin—stomach cancer	0.000103	0.000307	CcSEcCtD
Ketorolac—Chest pain—Doxorubicin—stomach cancer	0.000103	0.000307	CcSEcCtD
Ketorolac—Myalgia—Doxorubicin—stomach cancer	0.000103	0.000307	CcSEcCtD
Ketorolac—Anxiety—Doxorubicin—stomach cancer	0.000102	0.000306	CcSEcCtD
Ketorolac—Paraesthesia—Methotrexate—stomach cancer	0.000102	0.000305	CcSEcCtD
Ketorolac—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000102	0.000305	CcSEcCtD
Ketorolac—Discomfort—Doxorubicin—stomach cancer	0.000101	0.000303	CcSEcCtD
Ketorolac—Anorexia—Epirubicin—stomach cancer	0.000101	0.000303	CcSEcCtD
Ketorolac—Dyspnoea—Methotrexate—stomach cancer	0.000101	0.000303	CcSEcCtD
Ketorolac—Somnolence—Methotrexate—stomach cancer	0.000101	0.000302	CcSEcCtD
Ketorolac—Dizziness—Capecitabine—stomach cancer	0.000101	0.000302	CcSEcCtD
Ketorolac—Dry mouth—Doxorubicin—stomach cancer	0.0001	0.0003	CcSEcCtD
Ketorolac—Vomiting—Docetaxel—stomach cancer	0.0001	0.0003	CcSEcCtD
Ketorolac—Dyspepsia—Methotrexate—stomach cancer	0.0001	0.000299	CcSEcCtD
Ketorolac—Rash—Docetaxel—stomach cancer	9.95e-05	0.000297	CcSEcCtD
Ketorolac—Hypotension—Epirubicin—stomach cancer	9.95e-05	0.000297	CcSEcCtD
Ketorolac—Dermatitis—Docetaxel—stomach cancer	9.94e-05	0.000297	CcSEcCtD
Ketorolac—Confusional state—Doxorubicin—stomach cancer	9.93e-05	0.000297	CcSEcCtD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—stomach cancer	9.93e-05	0.00209	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—IDH3B—stomach cancer	9.9e-05	0.00209	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—SUCLG1—stomach cancer	9.9e-05	0.00209	CbGpPWpGaD
Ketorolac—Decreased appetite—Methotrexate—stomach cancer	9.89e-05	0.000295	CcSEcCtD
Ketorolac—Headache—Docetaxel—stomach cancer	9.89e-05	0.000295	CcSEcCtD
Ketorolac—Oedema—Doxorubicin—stomach cancer	9.85e-05	0.000294	CcSEcCtD
Ketorolac—Anaphylactic shock—Doxorubicin—stomach cancer	9.85e-05	0.000294	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Methotrexate—stomach cancer	9.82e-05	0.000293	CcSEcCtD
Ketorolac—Fatigue—Methotrexate—stomach cancer	9.81e-05	0.000293	CcSEcCtD
Ketorolac—Infection—Doxorubicin—stomach cancer	9.78e-05	0.000292	CcSEcCtD
Ketorolac—PTGS2—C-MYB transcription factor network—CDKN1B—stomach cancer	9.76e-05	0.00206	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—SMAD4—stomach cancer	9.76e-05	0.00206	CbGpPWpGaD
Ketorolac—Pain—Methotrexate—stomach cancer	9.73e-05	0.00029	CcSEcCtD
Ketorolac—Vomiting—Capecitabine—stomach cancer	9.71e-05	0.00029	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Epirubicin—stomach cancer	9.7e-05	0.00029	CcSEcCtD
Ketorolac—Shock—Doxorubicin—stomach cancer	9.69e-05	0.000289	CcSEcCtD
Ketorolac—Nervous system disorder—Doxorubicin—stomach cancer	9.66e-05	0.000288	CcSEcCtD
Ketorolac—Thrombocytopenia—Doxorubicin—stomach cancer	9.64e-05	0.000288	CcSEcCtD
Ketorolac—PTGS2—Metabolism—ACAD8—stomach cancer	9.64e-05	0.00203	CbGpPWpGaD
Ketorolac—Rash—Capecitabine—stomach cancer	9.63e-05	0.000288	CcSEcCtD
Ketorolac—Insomnia—Epirubicin—stomach cancer	9.63e-05	0.000287	CcSEcCtD
Ketorolac—Dermatitis—Capecitabine—stomach cancer	9.62e-05	0.000287	CcSEcCtD
Ketorolac—Tachycardia—Doxorubicin—stomach cancer	9.61e-05	0.000287	CcSEcCtD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—TYMS—stomach cancer	9.59e-05	0.00202	CbGpPWpGaD
Ketorolac—Headache—Capecitabine—stomach cancer	9.57e-05	0.000286	CcSEcCtD
Ketorolac—Skin disorder—Doxorubicin—stomach cancer	9.57e-05	0.000286	CcSEcCtD
Ketorolac—Paraesthesia—Epirubicin—stomach cancer	9.56e-05	0.000285	CcSEcCtD
Ketorolac—Hyperhidrosis—Doxorubicin—stomach cancer	9.52e-05	0.000284	CcSEcCtD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—HRAS—stomach cancer	9.5e-05	0.002	CbGpPWpGaD
Ketorolac—Dyspnoea—Epirubicin—stomach cancer	9.49e-05	0.000283	CcSEcCtD
Ketorolac—Somnolence—Epirubicin—stomach cancer	9.46e-05	0.000283	CcSEcCtD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—ECHS1—stomach cancer	9.42e-05	0.00199	CbGpPWpGaD
Ketorolac—Anorexia—Doxorubicin—stomach cancer	9.39e-05	0.00028	CcSEcCtD
Ketorolac—Nausea—Docetaxel—stomach cancer	9.37e-05	0.00028	CcSEcCtD
Ketorolac—Feeling abnormal—Methotrexate—stomach cancer	9.37e-05	0.00028	CcSEcCtD
Ketorolac—Dyspepsia—Epirubicin—stomach cancer	9.37e-05	0.00028	CcSEcCtD
Ketorolac—PTGS2—C-MYB transcription factor network—CCND1—stomach cancer	9.31e-05	0.00197	CbGpPWpGaD
Ketorolac—Gastrointestinal pain—Methotrexate—stomach cancer	9.3e-05	0.000278	CcSEcCtD
Ketorolac—Decreased appetite—Epirubicin—stomach cancer	9.25e-05	0.000276	CcSEcCtD
Ketorolac—PTGS2—Selenium Micronutrient Network—IL1B—stomach cancer	9.24e-05	0.00195	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—NDUFS1—stomach cancer	9.2e-05	0.00194	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—NDUFV1—stomach cancer	9.2e-05	0.00194	CbGpPWpGaD
Ketorolac—Hypotension—Doxorubicin—stomach cancer	9.2e-05	0.000275	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Epirubicin—stomach cancer	9.19e-05	0.000274	CcSEcCtD
Ketorolac—Fatigue—Epirubicin—stomach cancer	9.18e-05	0.000274	CcSEcCtD
Ketorolac—Constipation—Epirubicin—stomach cancer	9.1e-05	0.000272	CcSEcCtD
Ketorolac—Pain—Epirubicin—stomach cancer	9.1e-05	0.000272	CcSEcCtD
Ketorolac—Nausea—Capecitabine—stomach cancer	9.07e-05	0.000271	CcSEcCtD
Ketorolac—Urticaria—Methotrexate—stomach cancer	9.04e-05	0.00027	CcSEcCtD
Ketorolac—PTGS2—C-MYB transcription factor network—CDKN1A—stomach cancer	9.01e-05	0.0019	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	9e-05	0.0019	CbGpPWpGaD
Ketorolac—Body temperature increased—Methotrexate—stomach cancer	8.99e-05	0.000269	CcSEcCtD
Ketorolac—Abdominal pain—Methotrexate—stomach cancer	8.99e-05	0.000269	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Doxorubicin—stomach cancer	8.97e-05	0.000268	CcSEcCtD
Ketorolac—Insomnia—Doxorubicin—stomach cancer	8.91e-05	0.000266	CcSEcCtD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—FADS1—stomach cancer	8.86e-05	0.00187	CbGpPWpGaD
Ketorolac—Paraesthesia—Doxorubicin—stomach cancer	8.84e-05	0.000264	CcSEcCtD
Ketorolac—Dyspnoea—Doxorubicin—stomach cancer	8.78e-05	0.000262	CcSEcCtD
Ketorolac—Feeling abnormal—Epirubicin—stomach cancer	8.77e-05	0.000262	CcSEcCtD
Ketorolac—Somnolence—Doxorubicin—stomach cancer	8.75e-05	0.000261	CcSEcCtD
Ketorolac—Gastrointestinal pain—Epirubicin—stomach cancer	8.7e-05	0.00026	CcSEcCtD
Ketorolac—PTGS2—Spinal Cord Injury—RHOA—stomach cancer	8.68e-05	0.00183	CbGpPWpGaD
Ketorolac—Dyspepsia—Doxorubicin—stomach cancer	8.67e-05	0.000259	CcSEcCtD
Ketorolac—PTGS2—Metabolism—GMPR2—stomach cancer	8.59e-05	0.00181	CbGpPWpGaD
Ketorolac—Decreased appetite—Doxorubicin—stomach cancer	8.56e-05	0.000256	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Doxorubicin—stomach cancer	8.5e-05	0.000254	CcSEcCtD
Ketorolac—Fatigue—Doxorubicin—stomach cancer	8.49e-05	0.000254	CcSEcCtD
Ketorolac—Urticaria—Epirubicin—stomach cancer	8.46e-05	0.000253	CcSEcCtD
Ketorolac—PTGS1—Selenium Micronutrient Network—TNF—stomach cancer	8.45e-05	0.00178	CbGpPWpGaD
Ketorolac—Constipation—Doxorubicin—stomach cancer	8.42e-05	0.000252	CcSEcCtD
Ketorolac—Pain—Doxorubicin—stomach cancer	8.42e-05	0.000252	CcSEcCtD
Ketorolac—Body temperature increased—Epirubicin—stomach cancer	8.41e-05	0.000251	CcSEcCtD
Ketorolac—Abdominal pain—Epirubicin—stomach cancer	8.41e-05	0.000251	CcSEcCtD
Ketorolac—Hypersensitivity—Methotrexate—stomach cancer	8.38e-05	0.00025	CcSEcCtD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—SREBF2—stomach cancer	8.3e-05	0.00175	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PGLS—stomach cancer	8.2e-05	0.00173	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—BLVRB—stomach cancer	8.2e-05	0.00173	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—RORA—stomach cancer	8.2e-05	0.00173	CbGpPWpGaD
Ketorolac—Asthenia—Methotrexate—stomach cancer	8.16e-05	0.000244	CcSEcCtD
Ketorolac—Feeling abnormal—Doxorubicin—stomach cancer	8.12e-05	0.000242	CcSEcCtD
Ketorolac—Gastrointestinal pain—Doxorubicin—stomach cancer	8.05e-05	0.000241	CcSEcCtD
Ketorolac—Pruritus—Methotrexate—stomach cancer	8.05e-05	0.00024	CcSEcCtD
Ketorolac—PTGS2—Metabolism—IDH3B—stomach cancer	7.86e-05	0.00166	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—SUCLG1—stomach cancer	7.86e-05	0.00166	CbGpPWpGaD
Ketorolac—Hypersensitivity—Epirubicin—stomach cancer	7.84e-05	0.000234	CcSEcCtD
Ketorolac—PTGS1—Metabolism—PPAP2A—stomach cancer	7.83e-05	0.00165	CbGpPWpGaD
Ketorolac—Urticaria—Doxorubicin—stomach cancer	7.82e-05	0.000234	CcSEcCtD
Ketorolac—Body temperature increased—Doxorubicin—stomach cancer	7.79e-05	0.000233	CcSEcCtD
Ketorolac—Abdominal pain—Doxorubicin—stomach cancer	7.79e-05	0.000233	CcSEcCtD
Ketorolac—Diarrhoea—Methotrexate—stomach cancer	7.78e-05	0.000232	CcSEcCtD
Ketorolac—PTGS2—Disease—PGLS—stomach cancer	7.78e-05	0.00164	CbGpPWpGaD
Ketorolac—Asthenia—Epirubicin—stomach cancer	7.64e-05	0.000228	CcSEcCtD
Ketorolac—PTGS2—Spinal Cord Injury—CXCL8—stomach cancer	7.62e-05	0.00161	CbGpPWpGaD
Ketorolac—Pruritus—Epirubicin—stomach cancer	7.53e-05	0.000225	CcSEcCtD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	7.53e-05	0.00159	CbGpPWpGaD
Ketorolac—Dizziness—Methotrexate—stomach cancer	7.52e-05	0.000225	CcSEcCtD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—stomach cancer	7.48e-05	0.00158	CbGpPWpGaD
Ketorolac—PTGS2—C-MYB transcription factor network—MYC—stomach cancer	7.47e-05	0.00158	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—CDKN1B—stomach cancer	7.44e-05	0.00157	CbGpPWpGaD
Ketorolac—PTGS2—Disease—RBP1—stomach cancer	7.42e-05	0.00157	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—IL1B—stomach cancer	7.31e-05	0.00154	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—NDUFV1—stomach cancer	7.31e-05	0.00154	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—NDUFS1—stomach cancer	7.31e-05	0.00154	CbGpPWpGaD
Ketorolac—Diarrhoea—Epirubicin—stomach cancer	7.28e-05	0.000217	CcSEcCtD
Ketorolac—Hypersensitivity—Doxorubicin—stomach cancer	7.26e-05	0.000217	CcSEcCtD
Ketorolac—Vomiting—Methotrexate—stomach cancer	7.23e-05	0.000216	CcSEcCtD
Ketorolac—Rash—Methotrexate—stomach cancer	7.17e-05	0.000214	CcSEcCtD
Ketorolac—Dermatitis—Methotrexate—stomach cancer	7.16e-05	0.000214	CcSEcCtD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	7.14e-05	0.00151	CbGpPWpGaD
Ketorolac—Headache—Methotrexate—stomach cancer	7.12e-05	0.000213	CcSEcCtD
Ketorolac—PTGS2—Spinal Cord Injury—CCND1—stomach cancer	7.1e-05	0.0015	CbGpPWpGaD
Ketorolac—Asthenia—Doxorubicin—stomach cancer	7.07e-05	0.000211	CcSEcCtD
Ketorolac—Dizziness—Epirubicin—stomach cancer	7.04e-05	0.00021	CcSEcCtD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—APC—stomach cancer	7.04e-05	0.00148	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—CKB—stomach cancer	6.98e-05	0.00147	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—CA1—stomach cancer	6.98e-05	0.00147	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—NDUFA2—stomach cancer	6.98e-05	0.00147	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—FBP1—stomach cancer	6.98e-05	0.00147	CbGpPWpGaD
Ketorolac—Pruritus—Doxorubicin—stomach cancer	6.97e-05	0.000208	CcSEcCtD
Ketorolac—PTGS2—C-MYB transcription factor network—KRAS—stomach cancer	6.9e-05	0.00146	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—MMP9—stomach cancer	6.89e-05	0.00145	CbGpPWpGaD
Ketorolac—PTGS1—Selenium Micronutrient Network—IL6—stomach cancer	6.82e-05	0.00144	CbGpPWpGaD
Ketorolac—Vomiting—Epirubicin—stomach cancer	6.77e-05	0.000202	CcSEcCtD
Ketorolac—Nausea—Methotrexate—stomach cancer	6.76e-05	0.000202	CcSEcCtD
Ketorolac—Diarrhoea—Doxorubicin—stomach cancer	6.74e-05	0.000201	CcSEcCtD
Ketorolac—Rash—Epirubicin—stomach cancer	6.71e-05	0.0002	CcSEcCtD
Ketorolac—Dermatitis—Epirubicin—stomach cancer	6.7e-05	0.0002	CcSEcCtD
Ketorolac—PTGS2—Selenium Micronutrient Network—TNF—stomach cancer	6.7e-05	0.00141	CbGpPWpGaD
Ketorolac—Headache—Epirubicin—stomach cancer	6.67e-05	0.000199	CcSEcCtD
Ketorolac—PTGS2—Disease—FBP1—stomach cancer	6.61e-05	0.0014	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PLIN2—stomach cancer	6.56e-05	0.00138	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—stomach cancer	6.55e-05	0.00138	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PGLS—stomach cancer	6.51e-05	0.00137	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—BLVRB—stomach cancer	6.51e-05	0.00137	CbGpPWpGaD
Ketorolac—Dizziness—Doxorubicin—stomach cancer	6.51e-05	0.000194	CcSEcCtD
Ketorolac—PTGS1—Metabolism—CA2—stomach cancer	6.38e-05	0.00135	CbGpPWpGaD
Ketorolac—Nausea—Epirubicin—stomach cancer	6.32e-05	0.000189	CcSEcCtD
Ketorolac—Vomiting—Doxorubicin—stomach cancer	6.26e-05	0.000187	CcSEcCtD
Ketorolac—PTGS1—Metabolism—NT5E—stomach cancer	6.22e-05	0.00131	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PGAM1—stomach cancer	6.22e-05	0.00131	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PPAP2A—stomach cancer	6.21e-05	0.00131	CbGpPWpGaD
Ketorolac—Rash—Doxorubicin—stomach cancer	6.21e-05	0.000185	CcSEcCtD
Ketorolac—Dermatitis—Doxorubicin—stomach cancer	6.2e-05	0.000185	CcSEcCtD
Ketorolac—Headache—Doxorubicin—stomach cancer	6.17e-05	0.000184	CcSEcCtD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	5.97e-05	0.00126	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—ALDH7A1—stomach cancer	5.93e-05	0.00125	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PLCE1—stomach cancer	5.93e-05	0.00125	CbGpPWpGaD
Ketorolac—PTGS2—Disease—PGAM1—stomach cancer	5.89e-05	0.00124	CbGpPWpGaD
Ketorolac—PTGS2—C-MYB transcription factor network—HRAS—stomach cancer	5.87e-05	0.00124	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—MAPK3—stomach cancer	5.85e-05	0.00123	CbGpPWpGaD
Ketorolac—Nausea—Doxorubicin—stomach cancer	5.85e-05	0.000175	CcSEcCtD
Ketorolac—PTGS2—Spinal Cord Injury—MYC—stomach cancer	5.69e-05	0.0012	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—UMPS—stomach cancer	5.69e-05	0.0012	CbGpPWpGaD
Ketorolac—PTGS2—Disease—WIF1—stomach cancer	5.62e-05	0.00119	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—MAPK1—stomach cancer	5.57e-05	0.00117	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—EGFR—stomach cancer	5.57e-05	0.00117	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CKB—stomach cancer	5.54e-05	0.00117	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CA1—stomach cancer	5.54e-05	0.00117	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—NDUFA2—stomach cancer	5.54e-05	0.00117	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—FBP1—stomach cancer	5.54e-05	0.00117	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—stomach cancer	5.46e-05	0.00115	CbGpPWpGaD
Ketorolac—PTGS2—Selenium Micronutrient Network—IL6—stomach cancer	5.41e-05	0.00114	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—TNF—stomach cancer	5.3e-05	0.00112	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PDHA1—stomach cancer	5.29e-05	0.00112	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—ECHS1—stomach cancer	5.29e-05	0.00112	CbGpPWpGaD
Ketorolac—PTGS2—Disease—RPL18—stomach cancer	5.29e-05	0.00112	CbGpPWpGaD
Ketorolac—PTGS2—Disease—RPL13—stomach cancer	5.29e-05	0.00112	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PLIN2—stomach cancer	5.21e-05	0.0011	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CA2—stomach cancer	5.06e-05	0.00107	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—stomach cancer	5.06e-05	0.00107	CbGpPWpGaD
Ketorolac—PTGS2—Disease—RNF43—stomach cancer	5.01e-05	0.00106	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—TYMP—stomach cancer	4.97e-05	0.00105	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—FADS1—stomach cancer	4.97e-05	0.00105	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PGAM1—stomach cancer	4.94e-05	0.00104	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—NT5E—stomach cancer	4.94e-05	0.00104	CbGpPWpGaD
Ketorolac—PTGS2—Disease—RPS21—stomach cancer	4.93e-05	0.00104	CbGpPWpGaD
Ketorolac—PTGS2—Disease—RPS15—stomach cancer	4.93e-05	0.00104	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—stomach cancer	4.83e-05	0.00102	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—stomach cancer	4.82e-05	0.00102	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PLCE1—stomach cancer	4.71e-05	0.000994	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ALDH7A1—stomach cancer	4.71e-05	0.000994	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—TP53—stomach cancer	4.67e-05	0.000986	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—stomach cancer	4.67e-05	0.000985	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—SREBF2—stomach cancer	4.65e-05	0.000982	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—RORA—stomach cancer	4.6e-05	0.00097	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—stomach cancer	4.56e-05	0.000962	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—UMPS—stomach cancer	4.51e-05	0.000953	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—ALDOB—stomach cancer	4.31e-05	0.000909	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—IL6—stomach cancer	4.28e-05	0.000903	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—stomach cancer	4.21e-05	0.000888	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ECHS1—stomach cancer	4.2e-05	0.000886	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PDHA1—stomach cancer	4.2e-05	0.000886	CbGpPWpGaD
Ketorolac—PTGS2—Disease—ALDOB—stomach cancer	4.08e-05	0.000862	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	4.06e-05	0.000857	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	4.05e-05	0.000856	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—ALOX5—stomach cancer	4.01e-05	0.000845	CbGpPWpGaD
Ketorolac—PTGS2—Disease—RPL15—stomach cancer	4.01e-05	0.000845	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—stomach cancer	3.98e-05	0.00084	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—TYMP—stomach cancer	3.95e-05	0.000833	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—FADS1—stomach cancer	3.95e-05	0.000833	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—DPYD—stomach cancer	3.94e-05	0.000832	CbGpPWpGaD
Ketorolac—PTGS2—Disease—NPM1—stomach cancer	3.93e-05	0.00083	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—stomach cancer	3.87e-05	0.000817	CbGpPWpGaD
Ketorolac—PTGS2—Disease—RBP4—stomach cancer	3.8e-05	0.000801	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	3.79e-05	0.000799	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	3.79e-05	0.000799	CbGpPWpGaD
Ketorolac—PTGS2—Disease—RPS26—stomach cancer	3.74e-05	0.000788	CbGpPWpGaD
Ketorolac—PTGS2—Disease—PPIA—stomach cancer	3.71e-05	0.000782	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—SREBF2—stomach cancer	3.69e-05	0.00078	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—RORA—stomach cancer	3.65e-05	0.00077	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	3.61e-05	0.000761	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	3.58e-05	0.000755	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	3.57e-05	0.000754	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—GSTT1—stomach cancer	3.49e-05	0.000735	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—CYP2A6—stomach cancer	3.45e-05	0.000727	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ALDOB—stomach cancer	3.42e-05	0.000722	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—AKR1C3—stomach cancer	3.35e-05	0.000707	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	3.29e-05	0.000694	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—ENO1—stomach cancer	3.27e-05	0.000689	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	3.23e-05	0.000681	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	3.22e-05	0.000679	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—ALB—stomach cancer	3.21e-05	0.000678	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ALOX5—stomach cancer	3.18e-05	0.000671	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	3.18e-05	0.000671	CbGpPWpGaD
Ketorolac—PTGS2—Disease—RPS19—stomach cancer	3.18e-05	0.00067	CbGpPWpGaD
Ketorolac—PTGS2—Disease—AKR1C3—stomach cancer	3.18e-05	0.00067	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—DPYD—stomach cancer	3.13e-05	0.00066	CbGpPWpGaD
Ketorolac—PTGS2—Disease—ENO1—stomach cancer	3.1e-05	0.000653	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—CD44—stomach cancer	2.9e-05	0.000611	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	2.84e-05	0.000598	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	2.81e-05	0.000593	CbGpPWpGaD
Ketorolac—PTGS2—Disease—RPS6—stomach cancer	2.81e-05	0.000593	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—GSTT1—stomach cancer	2.77e-05	0.000584	CbGpPWpGaD
Ketorolac—PTGS2—Disease—CD44—stomach cancer	2.75e-05	0.000579	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CYP2A6—stomach cancer	2.73e-05	0.000577	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—AKR1C3—stomach cancer	2.66e-05	0.000561	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ENO1—stomach cancer	2.59e-05	0.000547	CbGpPWpGaD
Ketorolac—PTGS2—Disease—HBEGF—stomach cancer	2.58e-05	0.000545	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—ALB—stomach cancer	2.55e-05	0.000538	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PPP2R1A—stomach cancer	2.46e-05	0.00052	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—GSTP1—stomach cancer	2.42e-05	0.00051	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—HMOX1—stomach cancer	2.38e-05	0.000503	CbGpPWpGaD
Ketorolac—PTGS2—Disease—PPP2R1A—stomach cancer	2.33e-05	0.000493	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CD44—stomach cancer	2.3e-05	0.000485	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—TYMS—stomach cancer	2.25e-05	0.000474	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—GSTM1—stomach cancer	2.22e-05	0.000468	CbGpPWpGaD
Ketorolac—PTGS2—Disease—SMAD4—stomach cancer	2.17e-05	0.000457	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—ERCC2—stomach cancer	2.09e-05	0.00044	CbGpPWpGaD
Ketorolac—PTGS2—Disease—FYN—stomach cancer	2.06e-05	0.000434	CbGpPWpGaD
Ketorolac—PTGS2—Disease—ERCC2—stomach cancer	1.98e-05	0.000417	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—MTHFR—stomach cancer	1.96e-05	0.000414	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PPP2R1A—stomach cancer	1.96e-05	0.000413	CbGpPWpGaD
Ketorolac—PTGS2—Disease—FGFR2—stomach cancer	1.93e-05	0.000408	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—GSTP1—stomach cancer	1.92e-05	0.000405	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—HMOX1—stomach cancer	1.89e-05	0.000399	CbGpPWpGaD
Ketorolac—PTGS2—Disease—MTHFR—stomach cancer	1.86e-05	0.000392	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—CAV1—stomach cancer	1.81e-05	0.000382	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—APOA1—stomach cancer	1.81e-05	0.000381	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—TYMS—stomach cancer	1.78e-05	0.000376	CbGpPWpGaD
Ketorolac—PTGS2—Disease—IRS2—stomach cancer	1.77e-05	0.000373	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—GSTM1—stomach cancer	1.76e-05	0.000372	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.73e-05	0.000365	CbGpPWpGaD
Ketorolac—PTGS2—Disease—CAV1—stomach cancer	1.72e-05	0.000362	CbGpPWpGaD
Ketorolac—PTGS2—Disease—APOA1—stomach cancer	1.71e-05	0.000361	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ERCC2—stomach cancer	1.66e-05	0.00035	CbGpPWpGaD
Ketorolac—PTGS2—Disease—IL6ST—stomach cancer	1.63e-05	0.000343	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PPARG—stomach cancer	1.59e-05	0.000336	CbGpPWpGaD
Ketorolac—PTGS2—Disease—APC—stomach cancer	1.56e-05	0.00033	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—MTHFR—stomach cancer	1.56e-05	0.000329	CbGpPWpGaD
Ketorolac—PTGS2—Disease—IL6R—stomach cancer	1.45e-05	0.000306	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CAV1—stomach cancer	1.44e-05	0.000303	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—APOA1—stomach cancer	1.43e-05	0.000302	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—ALB—stomach cancer	1.43e-05	0.000302	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.37e-05	0.00029	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—NOS3—stomach cancer	1.37e-05	0.000289	CbGpPWpGaD
Ketorolac—PTGS2—Disease—SERPINE1—stomach cancer	1.36e-05	0.000287	CbGpPWpGaD
Ketorolac—PTGS2—Disease—RHOA—stomach cancer	1.31e-05	0.000277	CbGpPWpGaD
Ketorolac—PTGS2—Disease—NOS3—stomach cancer	1.3e-05	0.000274	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PPARG—stomach cancer	1.26e-05	0.000267	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PTGS2—stomach cancer	1.25e-05	0.000264	CbGpPWpGaD
Ketorolac—PTGS2—Disease—ERBB2—stomach cancer	1.21e-05	0.000256	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ALB—stomach cancer	1.14e-05	0.00024	CbGpPWpGaD
Ketorolac—PTGS2—Disease—CDKN1B—stomach cancer	1.12e-05	0.000237	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—NOS3—stomach cancer	1.09e-05	0.000229	CbGpPWpGaD
Ketorolac—PTGS2—Disease—CDKN1A—stomach cancer	1.04e-05	0.000219	CbGpPWpGaD
Ketorolac—PTGS2—Disease—STAT3—stomach cancer	9.25e-06	0.000195	CbGpPWpGaD
Ketorolac—PTGS2—Disease—MAPK3—stomach cancer	8.84e-06	0.000187	CbGpPWpGaD
Ketorolac—PTGS2—Disease—MYC—stomach cancer	8.6e-06	0.000181	CbGpPWpGaD
Ketorolac—PTGS2—Disease—MAPK1—stomach cancer	8.41e-06	0.000177	CbGpPWpGaD
Ketorolac—PTGS2—Disease—EGFR—stomach cancer	8.41e-06	0.000177	CbGpPWpGaD
Ketorolac—PTGS2—Disease—KRAS—stomach cancer	7.94e-06	0.000168	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PIK3CA—stomach cancer	7.7e-06	0.000162	CbGpPWpGaD
Ketorolac—PTGS2—Disease—PIK3CA—stomach cancer	7.3e-06	0.000154	CbGpPWpGaD
Ketorolac—PTGS2—Disease—HRAS—stomach cancer	6.75e-06	0.000142	CbGpPWpGaD
Ketorolac—PTGS2—Disease—IL6—stomach cancer	6.46e-06	0.000136	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PIK3CA—stomach cancer	6.11e-06	0.000129	CbGpPWpGaD
